Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crushed versus whole prasugrel tablets in pre-hospital STEMI primary PCI
2017-002419-32Phase 4Completed
- Sponsor
- Research Maatschap Cardiologen Rijnmond Zuid
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prasugrel in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Research Maatschap Cardiologen Rijnmond Zuid. Primary endpoints: TIMI flow grade 3 of MI culprit vessel at initial angiography and ST-segment resolution at 60 minutes post-PCI. Started Aug 2017; status: completed.
02
Drugs
prasugrel
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2017-002419-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002419-32.